Brind.
  1. FDA approved Lupin's drug application, confirming its bioequivalence to AstraZeneca's reference drug.

U.S. FDA granted final approval for Pitolisant Tablets, confirming its bioequivalence to Wakix®.

1 report, 1 independent Updated Aug 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

U.S. FDA granted final approval for Pitolisant Tablets, confirming its bioequivalence to Wakix®.

Who's involved

What this event is mainly about
United States Food and Drug Administration

Keep exploring

Part of

FDA approved Lupin's drug application, confirming its bioequivalence to AstraZeneca's reference drug. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped